At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
We aspire to transform patients’ lives and Biogen by making personalized & digital medicine in neuroscience a reality. Powered by data science and digital technologies, we drive solutions to advance research, clinical care, and patient empowerment. We believe that now, more than ever, biology and technology should go hand-in-hand to better meet patient needs, while enabling a shift towards more prevention-focused, affordable, and equitable care.
Biogen contributes to the communities where we live. We are committed to our employees, diversity, equity and inclusion, and environmental sustainability.
We came to Biogen to solve the unsolvable. We stay to create new possibilities and grow together. We work fearlessly and go beyond because we care deeply about making a difference and changing lives. All legitimate correspondence from a Biogen employee will come from “@biogen.com” or “@smartrecruiters.com” email accounts.
First and foremost, Biogen is heartbroken by the war in Ukraine, and stands firmly with the global community in providing humanitarian aid. Consistent with our values, the Biogen Foundation has provided a $250,000 grant as well as launched an employee giving campaign that doubles employee’s contributions to provide medical supplies, food, water, shelter, and other essential support. Our contributions to date have surpassed more than $1 million in grants, in-kind materials, volunteering, and other support.
Biogen does not have an operational footprint in Russia. Given the uniqueness of our industry and the fact that we provide life-saving medicines to people, we continue to supply some of our unique medicines to people in Russia through a collaboration with another American company. Our portfolio notably includes SPINRAZA for spinal muscular atrophy (SMA) and some of our multiple sclerosis products. This approach is aligned with international law and follows Biogen’s principles of putting patients first.
We are closely monitoring this evolving situation.
The foundation of Biogen’s philosophy – Caring Deeply – can be seen in the ways we engage with the communities where we work.
At Biogen, we are dedicated to inspiring the next generation of scientists through our support of youth and science, technology, engineering, and mathematics (STEM) education and to being agents of positive change with lasting impact by building stronger and healthier communities.
We aspire to be a positive presence wherever we operate, demonstrated by our employee volunteerism efforts, such as Care Deeply Day, the grants we make through the Biogen Foundation and our unique, hands-on Community Labs, which have provided more than 50,000 students a hands-on introduction to the wonders of science since 2002.
Biogen Foundation
The Biogen Foundation supports access to science education and to essential human services for children and their families in the communities in which Biogen facilities are located. The Foundation is committed to sparking a passion for science and discovery, supporting effective science education initiatives and strengthening efforts to make science education and science careers accessible to diverse populations.
Most of all, we want young people to know that through science they have the ability to change the world.
The Biogen Foundation’s grant-making programs focus on access in two areas: science education and strengthening our communities. Today, the Biogen Foundation is committed to supporting nonprofit organizations that focus on providing access to:
Hands-on science education
Teacher development opportunities in science
College readiness and support
Basic social needs (child hunger, poverty, and social mobility)
The Foundation also matches Biogen employee gifts to nonprofit organizations, up to $25,000 per employee, per year. In 2018, the matching grant program contributed $1.35 million to worthy organizations ranging from disease organizations and camps for children with serious illnesses to disaster relief efforts.
U.S. Grants Program provides access to science education programs and essential human services to children and their families in the communities in which Biogen has facilities in the U.S. – specifically in Greater Boston and North Carolina. The Foundation’s fiscal year is the calendar year and grant applications are considered on a quarterly basis throughout the year.
International Grants Program provides access to science education programs in the communities in which Biogen has facilities around the world. Beneficiaries have included the Experimentarium in Denmark, Technorama Science Center in Switzerland and Science Lab in Germany. Participation in the International Grants Program is by invitation only.
U.S. Employee Matching Gifts Program matches Biogen employee gifts to non-profit organizations — maximizing community benefit and demonstrating the powerful difference we can collectively make in the lives of others. The Foundation matches Biogen employee donations to eligible organizations dollar-for-dollar, up to $25,000 per employee, per year.
Important Notice:
You are now leaving Biogen’s corporate website.
We encourage you to read and evaluate terms of use, privacy, security and other similar policies of the destination site as they may differ from Biogen’s standards.
Third Party Sites
Biogen assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site's endorsement of Biogen or this website.